Landscapes / Companies

Ipsen not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 approved
2 in Phase 3
Next date
Corabotase, Phase 3 trial completes
Drugs
10
in active trials · 40 in all
Trials
21 active
88 since 2021

Drugs10

DrugHow it worksPartnerStageNext dateDetails
Peroxisome proliferator-activated receptor agonist
Approved 17 Dec 2026soonPhase 3 trial completes
Acetylcholine release Inhibitor; neuromuscular blocker
Approved 19 Aug 2027Phase 1/2 trial completes
Kinase inhibitor
Day One Biopharmaceuticals
Approved 31 Jul 2030Phase 1 trial completes
—
Phase 3 15 Dec 2026soonPhase 3 trial completes
—
ImCheck Therapeutics, an Ipsen company
Phase 2/3 15 Oct 2027Phase 1/2 trial completes
—
Phase 1/2 20 Mar 2028Phase 1/2 trial completes
—
Phase 1/2 4 Apr 2028Phase 1/2 trial completes
—
Phase 1/2 30 Oct 2028Phase 1/2 trial completes
IPN60350not checked
—
Phase 1/2 28 Jun 2030Phase 1/2 trial completes
—
Phase 1/2 14 Jul 2032Phase 1/2 trial completes

About

No active trial
30 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Ipsen

Following is part of Solo: you see every change to Ipsen the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in